Sentences with phrase «treats causes of disease»

«Bortezomib is capable of treating the causes of the disease by eliminating plasma cells.

Two theories are offered in The Tomato Effect and Lifestyle Medicine: Treating the Causes of Disease.

See: Lifestyle Medicine: Treating the Causes of Disease.

Not exact matches

(Though it's important to note that the treatment, Mitsubishi Tanabe Pharma America's Radicava, is mightily expensive and only treats symptom progression rather than the root cause of the disease.)

And the parasite that causes malaria is gaining resistance to some of the best drugs used to treat the disease, including artemisinin.

A detailed review from Entirely Pets speaks to the natural flavor of the treats as well as the efficacy of the dual - enzyme system in removing and preventing disease - causing plaque.

speaks to the natural flavor of the treats as well as the efficacy of the dual - enzyme system in removing and preventing disease - causing plaque.

If coeliac disease isn't treated, not being able to digest food in the normal way could cause you to become malnourished, leading to tiredness and a lack of energy.

However, the presence of any potentially disease - causing organisms in drinking water supplies is of concern, particularly to upstate communities that receive water from that part of the Catskill / Delaware system that has not been treated by the City's UV disinfection facility in Westchester County.

If so, does it cause Lyme - like symptoms, and what are the implications for diagnosing and treating people with these other forms of disease?

Researchers from Instituto de Medicina Molecular (iMM) Lisboa have created a chimera virus that allows the study of molecules to treat cancers caused by human herpes virus infection in mice models of disease.

According to infectious disease doctor and Lyme expert Benjamin Luft of Stony Brook University in New York, only certain strains of Northern Borrelia burgdorferi cause invasive Lyme disease, though it's accepted protocol to treat all Northern patients with antibiotics.

A new discovery from the University of Alberta's Faculty of Medicine & Dentistry could open the door to one day treat or prevent diseases caused by West Nile virus and Dengue virus infections.

While medications currently exist to treat lymphatic filariasis and onchocerciasis, the two main diseases caused by filarial nematodes, the drugs are insufficient to eliminate the diseases by 2020 and researchers project that resistance will arise to some of the drugs.

The study suggests PSC and PBC differ more than originally thought, Konstantinos Lazaridis, M.D., a Mayo Clinic hepatologist and senior study author says: «Moving forward, we can look at what this finding might tell us about the causes of these diseases and how to better treat them.»

«Suppressing a progenitor from creating the subtype of dendritic cells implicated in causing lupus, for example, could be an efficient way of treating autoimmune diseases while minimising the impact on the rest of the immune system.

«There might be nothing you can do about the fat being shuttled to the liver, but if you can prevent the fat from being toxic or from causing disease, then that might be the best way of treating this,» Miller said.

Together, the two studies advance the idea that gut microbes play a role in turning the immune system against nerve cells, causing MS.. It will take a lot more work to develop cures or preventive strategies based on that, but the research raises the intriguing possibility of treating an often - devastating disease with something as low - tech as fecal transplants or probiotics.

These findings have unnerved some clinicians because patients with a variety of diseases are treated with high - dose glucocorticoids for long periods (even though the treatment is known to cause memory problems) and because the body itself secretes a ton of these hormones during neurological crises.

The study, published online ahead of print in The Journal of Clinical Investigation, has implications for treating diseases such as diabetic retinopathy and age - related macular degeneration — the leading causes of vision loss in adults.

Researchers are far from a complete understanding of what causes schizophrenia and how it affects the brain, and some psychiatrists contend that treating a patient for a disease not yet manifest is a clear violation of a basic tenet of medicine: to do no harm.

Our study advances our knowledge of Sox9's role in causing this terrible disease — and brings us one step closer to understanding how to potentially treat it.»

p > In a study of 61 people treated for the bacteria that causes Lyme disease, Johns Hopkins researchers conclude that fatigue, pain, insomnia and depression do indeed persist over long periods of time for some people, despite largely normal physical exams and clinical laboratory testing.

And the scientists discovered that leaves treated with the fecal solution for 24 hours also had reduced growth of a fungus known to cause southern leaf blight disease in corn.

Such claims have linked the rise in occurrence of corn diseases like Goss's wilt, which causes leaf blight and systemic wilt, to the adoption of transgenic corn across the U.S.. However, a new study from the USDA - Agricultural Research Service (ARS) provides empirical evidence showing no increase in disease susceptibility in transgenic sweet corn treated with glyphosate.

The researchers used the compound to treat the nerves of mice harboring the genetic defects that cause the disease.

Many patients face delayed diagnosis and treatment, meaning the disease progresses and causes further ill health and risk of complications, for example myocardial infarction, blindness, and stroke, which are difficult and expensive to treat.

Moreover, her studies are the first to indicate that therapies targeted at controlling the properties of smooth muscle cells within lesions may be highly effective in treating a disease that is the leading cause of death worldwide.

The model, described in a study published this week in Biomicrofluidics, from AIP Publishing, will enable researchers to study potential disease causes and test new drugs to treat IBD, said study author Amy Dawson, a postdoctoral researcher in the lab of John Greenman at the University of Hull, U.K..

Dysevolution is what Lieberman calls «the deleterious feedback loop that occurs over multiple generations when we don't treat the causes of a mismatch disease but instead pass on whatever environmental factors cause the disease, keeping the disease prevalent and sometimes making it worse.»

A Michigan State University researcher is challenging a widely held African belief that a spinal tap, a procedure safely used to treat other diseases, could suck the brain from the base of the skull and cause death in malaria patients.

Researchers developed a new type of cell transplantation to treat mice mimicking a rare lung disease that one day could be used to treat this and other human lung diseases caused by dysfunctional immune cells.

The goal of the database is to identify DNA that causes genetic disorders and have a better understanding of how to treat diseases.

Also, as therapies are developed to treat protein - aggregation - based pathologies, it will be critical to consider that there may be many useful aggregates that should not be destroyed in the process of treating disease - causing aggregates.

Created by a multidisciplinary panel led by infectious diseases, pulmonary and critical care specialists, the new guidelines also recommend that each hospital develop an antibiogram, a regular analysis of the strains of bacteria causing pneumonia infections locally as well as which antibiotics effectively treat them.

While researching the molecular causes of heart failure and new ways to treat it, a Charité - based working group, led by Prof. Dr. Ulrich Kintscher, found that changes in adipose (fat) tissue lipid metabolism affect disease development.

As part of the new study, the researchers showed that intact axons without Phr1 were protected from the damage caused by vincristine, a chemotherapy drug used to treat leukemia, neuroblastoma, Hodgkin's disease and non-Hodgkin's lymphoma, among other cancers.

Hepatic encephalopathy occurs when the liver can not remove certain toxins and chemicals, such as ammonia, from the blood.1 These toxins and chemicals then build up and enter the brain.1 Hepatic encephalopathy is one of the major complications of cirrhosis (scarring of the liver), and a leading cause of hospital re-admission due to its recurrence, despite treatment.1 It can occur suddenly in people with acute liver failure, but is seen more often in those with chronic liver disease.1 Symptoms of hepatic encephalopathy include mild confusion, forgetfulness, poor concentration and personality or mood changes, but can progress to extreme anxiety, seizures, severe confusion, jumbled and slurred speech and slow movement.1 The first step in treatment is to identify and treat any factors that cause hepatic encephalopathy.2 Once the episode has resolved, further treatment aims to reduce the production and absorption of toxins, such as ammonia.1 Generally, there are two types of medication used to reduce the likelihood of another hepatic encephalopathy episode — lactulose and rifaximin.2 However, it remains a leading cause of hospitalisations and re-hospitalisations in cirrhotic patients, despite the use of the above - mentioned standard of care treatment.

Dicerna Pharmaceuticals, meanwhile, is preparing to enter the clinic with an RNAi drug that treats primary hyperoxaluria — a rare genetic disease that causes the overproduction and buildup of substances called oxalates in the urine.

The tool, freely available at http://zika.cidma.us/, can be used to interrogate a range of scenarios, and can be adjusted as we learn more about how the virus causes disease and the effectiveness of ways to prevent and treat infections.

The problem was particularly obvious in trials of drugs to treat heart disease, which is the leading cause of death in women.

This discovery, details of which have been published in the Proceedings of the National Academy of Sciences (PNAS), opens the door to new ways to treat patients with septic shock caused by viral or bacterial infection as well as people with auto - immune diseases like rheumatoid arthritis and lupus.

In reality, those diseases are probably caused by a wide variety of extremely rare mutations that vary from one person to the next, complicating efforts to understand and treat them at the genetic level.

«Secondary bacterial infections cause much of the sickness and about 25 percent of all deaths during the flu season, and 50 to 95 percent of deaths during pandemics of influenza,» says Jonathan McCullers, an infectious disease specialist at St. Jude Children's Research Hospital and co-author of a study that suggests a new way of treating such conditions.

More than one - third of the world's population is susceptible to active tuberculosis, so it is unfortunate that Sutherlandia, which traditionally is taken to prevent or treat infections, can actually cause them to develop the disease, and perhaps also cause the microbe to become a drug - resistant «super bug.»»

Researchers at Oregon State University have discovered novel proteins in, or on the surface of the bacteria that causes gonorrhea, which offer a promising new avenue of attack against a venereal disease that is showing increased resistance to the antibiotics used to treat it.

Palmer said the multi-site registry will help doctors who treat patients with idiopathic pulmonary fibrosis better understand how to diagnose and manage the disease, while it will also help researchers uncover the basic causes and mechanisms of the disease.

Though researchers believe that these substances could be used to treat conditions caused by the death of nerve cells, most of the factors previously investigated do little to protect the cells that are lost in Parkinson's and motor neuron disease.

«Because soil bacteria need many thousands of years to develop new antibiotics, the bacteria in that community don't encounter these threats anywhere near as often as disease - causing bacteria, which we regularly treat with different antibiotics.»

Economists point to two causes: the prevalence of diseases and conditions afflicting the U.S. population, or the rising costs of treating diseases.